BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Cushing K, Higgins PDR. Management of Crohn Disease: A Review. JAMA 2021;325:69-80. [PMID: 33399844 DOI: 10.1001/jama.2020.18936] [Cited by in Crossref: 38] [Cited by in F6Publishing: 27] [Article Influence: 38.0] [Reference Citation Analysis]
Number Citing Articles
1 Yang HH, Huang Y, Zhou XC, Wang RN. Efficacy and safety of adalimumab in comparison to infliximab for Crohn's disease: A systematic review and meta-analysis. World J Clin Cases 2022; 10(18): 6091-6104 [DOI: 10.12998/wjcc.v10.i18.6091] [Reference Citation Analysis]
2 Fan Y, Delgado-Aros S, Valdecantos WC, Janak JC, Moore PC, Crabtree MM, Stidham RW. Characteristics of Patients with Crohn's Disease With or Without Perianal Fistulae in the CorEvitas Inflammatory Bowel Disease Registry. Dig Dis Sci 2022. [PMID: 35467311 DOI: 10.1007/s10620-022-07491-y] [Reference Citation Analysis]
3 Ye C, Zhu S, Yuan J. Construction of ceRNA Network to Reveal Potential Biomarkers in Crohn's Disease and Validation in a TNBS Induced Mice Model. J Inflamm Res 2021;14:6447-59. [PMID: 34880646 DOI: 10.2147/JIR.S338053] [Reference Citation Analysis]
4 Cheng WX, Ren Y, Lu MM, Xu LL, Gao JG, Chen D, Kalyani FS, Lv ZY, Chen CX, Ji F, Lin HN, Jin X. Palmitoylation in Crohn’s disease: Current status and future directions. World J Gastroenterol 2021; 27(48): 8201-8215 [DOI: 10.3748/wjg.v27.i48.8201] [Reference Citation Analysis]
5 Cushing K, Higgins PDR. Management of Crohn Disease-Reply. JAMA 2021;325:1794-5. [PMID: 33944877 DOI: 10.1001/jama.2021.2921] [Reference Citation Analysis]
6 Ye C, Zhu S, Yuan J. Characterization of Two TNF-Related Subtypes Predicting Infliximab Therapy Responses in Crohn’s Disease. Front Immunol 2022;13:871312. [DOI: 10.3389/fimmu.2022.871312] [Reference Citation Analysis]
7 Bayoumy AB, de Boer NKH, Mulder CJJ. Management of Crohn Disease. JAMA 2021;325:1793-4. [PMID: 33944879 DOI: 10.1001/jama.2021.2918] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
8 Zheng Y, Yu Y, Chen XF, Yang SL, Tang XL, Xiang ZG. Intestinal Macrophage Autophagy and its Pharmacological Application in Inflammatory Bowel Disease. Front Pharmacol 2021;12:803686. [PMID: 34899362 DOI: 10.3389/fphar.2021.803686] [Reference Citation Analysis]
9 Kong N, Gao C, Zhang F, Zhang M, Yue J, Lv K, Zhang Q, Fan Y, Lv B, Zang Y, Xu M. Neurophysiological Effects of the Anterior Cingulate Cortex on the Exacerbation of Crohn’s Disease: A Combined fMRI-MRS Study. Front Neurosci 2022;16:840149. [DOI: 10.3389/fnins.2022.840149] [Reference Citation Analysis]
10 Rolak S, Kane SV. Conventional Therapies for Crohn's Disease. Gastroenterol Clin North Am 2022;51:271-82. [PMID: 35595414 DOI: 10.1016/j.gtc.2021.12.004] [Reference Citation Analysis]
11 Chen P, Huang S, Yu Q, Chao K, Wang Y, Zhou G, Zhuang X, Zeng Z, Chen M, Zhang S. Serum exosomal microRNA-144-3p: a promising biomarker for monitoring Crohn's disease. Gastroenterology Report 2021. [DOI: 10.1093/gastro/goab056] [Reference Citation Analysis]
12 Chen X, Wang D, Zheng F, Zhu L, Huang Y, Zhu Y, Huang Y, Xu H, Li Z. Effects of Posaconazole on Tacrolimus Population Pharmacokinetics and Initial Dose in Children With Crohn’s Disease Undergoing Hematopoietic Stem Cell Transplantation. Front Pharmacol 2022;13:758524. [DOI: 10.3389/fphar.2022.758524] [Reference Citation Analysis]
13 Haynie T, Gubler S, Drees C, Heaton T, Mitton T, Gleave Q, Bendelac A, Deng S, Savage PB. Synthesis of the pentasaccharide repeating unit from Ruminococcus gnavus and measurement of its inflammatory properties. RSC Adv 2021;11:14357-61. [DOI: 10.1039/d1ra01918j] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Liu C, Li N, Zhan S, Tian Z, Wu D, Li T, Zeng Z, Zhuang X. Anti -TNFα agents in preventing the postoperative recurrence of Crohn's disease: Do they still play a role in the biological era? Expert Opin Biol Ther 2021;:1-16. [PMID: 34350811 DOI: 10.1080/14712598.2021.1964469] [Reference Citation Analysis]
15 Nemirovsky A, Ilan K, Lerner L, Cohen-Lavi L, Schwartz D, Goren G, Sergienko R, Greenberg D, Slonim-Nevo V, Sarid O, Friger M, Regev S, Odes S, Hertz T, Monsonego A; Israeli IBD Research Nucleus (IIRN). Brain-immune axis regulation is responsive to cognitive behavioral therapy and mindfulness intervention: Observations from a randomized controlled trial in patients with Crohn's disease. Brain Behav Immun Health 2022;19:100407. [PMID: 35024638 DOI: 10.1016/j.bbih.2021.100407] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
16 Cannon AS, Nagarkatti PS, Nagarkatti M. Targeting AhR as a Novel Therapeutic Modality against Inflammatory Diseases. Int J Mol Sci 2021;23:288. [PMID: 35008717 DOI: 10.3390/ijms23010288] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
17 Jarmakiewicz-czaja S, Sokal A, Pardak P, Filip R, Granito A. Glucocorticosteroids and the Risk of NAFLD in Inflammatory Bowel Disease. Canadian Journal of Gastroenterology and Hepatology 2022;2022:1-13. [DOI: 10.1155/2022/4344905] [Reference Citation Analysis]
18 Ohliger MA. Quantitative Dual-Energy CT and Crohn Disease. Radiology 2021;:211415. [PMID: 34342507 DOI: 10.1148/radiol.2021211415] [Reference Citation Analysis]
19 Chen L, Wang J, Yi J, Liu Y, Yu Z, Chen S, Liu X. Increased mucin-degrading bacteria by high protein diet leads to thinner mucus layer and aggravates experimental colitis. J Gastroenterol Hepatol 2021. [PMID: 34050560 DOI: 10.1111/jgh.15562] [Reference Citation Analysis]
20 Snyder EF, Davis S, Aldrich K, Veerabagu M, Larussa T, Abenavoli L, Boccuto L. Crohn disease: Identification, diagnosis, and clinical management. Nurse Pract 2021;46:22-30. [PMID: 34808643 DOI: 10.1097/01.NPR.0000798212.61425.4f] [Reference Citation Analysis]
21 Qu P, Xie X, Chi J, Liu X, Liu P, Luo J, Li H, Cheng S, Xia X, Chen X, Xu C, Sun Y. Circulating Exosomal miR-144-3p from Crohn’s Disease Patients Inhibits Human Umbilical Vein Endothelial Cell Function by Targeting FN1. Disease Markers 2022;2022:1-12. [DOI: 10.1155/2022/8219557] [Reference Citation Analysis]
22 Yang L, Gao Y, Bajpai VK, El-Kammar HA, Simal-Gandara J, Cao H, Cheng KW, Wang M, Arroo RRJ, Zou L, Farag MA, Zhao Y, Xiao J. Advance toward isolation, extraction, metabolism and health benefits of kaempferol, a major dietary flavonoid with future perspectives. Crit Rev Food Sci Nutr 2021;:1-17. [PMID: 34554029 DOI: 10.1080/10408398.2021.1980762] [Reference Citation Analysis]
23 Yang C, Yu H, Hu X, Chen H, Wu H, Deng C, Sun N. Gold‐Doped Covalent Organic Framework Reveals Specific Serum Metabolic Fingerprints as Point of Crohn's Disease Diagnosis. Adv Funct Materials 2021;31:2105478. [DOI: 10.1002/adfm.202105478] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 10.0] [Reference Citation Analysis]
24 Xia K, Gao R, Wu X, Ruan Y, Wan J, Wu T, Wang F, Lin Y, Yin L, Chen C. Crohn's Disease Complicated by Rare Types of Intestinal Obstruction: Two Case Reports. Front Med (Lausanne) 2022;9:895202. [PMID: 35572975 DOI: 10.3389/fmed.2022.895202] [Reference Citation Analysis]
25 Wen H, Zhang X, Li Q, Huang J, Liu G, Zhao J, Liu Y, Shen L, Li Y, Yang K, Zuo L, Li J, Nian J, Xiang P, Zhao H, Yu L, Liu M, Geng Z, Song X, Tahmasbpour E. Ruscogenins Improve CD-Like Enteritis by Inhibiting Apoptosis of Intestinal Epithelial Cells and Activating Nrf2/NQO1 Pathway. Oxidative Medicine and Cellular Longevity 2022;2022:1-12. [DOI: 10.1155/2022/4877275] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
26 Kelm M, Germer CT, Schlegel N, Flemming S. The Revival of Surgery in Crohn's Disease-Early Intestinal Resection as a Reasonable Alternative in Localized Ileitis. Biomedicines 2021;9:1317. [PMID: 34680434 DOI: 10.3390/biomedicines9101317] [Reference Citation Analysis]
27 Sassine S, Savoie Robichaud M, Lin YF, Djani L, Cambron-Asselin C, Qaddouri M, Zekhnine S, Grzywacz K, Groleau V, Dirks M, Drouin É, Halac U, Marchand V, Girard C, Courbette O, Patey N, Dal Soglio D, Deslandres C, Jantchou P. Changes in the clinical phenotype and behavior of pediatric luminal Crohn's disease at diagnosis in the last decade. Dig Liver Dis 2021:S1590-8658(21)00783-0. [PMID: 34756526 DOI: 10.1016/j.dld.2021.09.012] [Reference Citation Analysis]
28 Rispo A, de Sire R, Mainenti PP, Imperatore N, Testa A, Maurea S, Ricciolino S, Nardone OM, Olmo O, Castiglione F. David Against Goliath: Direct Comparison of Handheld Bowel Sonography and Magnetic Resonance Enterography for Diagnosis of Crohn's Disease. Inflamm Bowel Dis 2022:izac116. [PMID: 35666249 DOI: 10.1093/ibd/izac116] [Reference Citation Analysis]
29 Qian L, Gu Y, Zheng L, Xia T. Diagnostic value of capsule endoscopy and double-balloon enteroscopy in small bowel diseases. Am J Transl Res 2022;14:328-35. [PMID: 35173850] [Reference Citation Analysis]